Richard D. Press, M.D., Ph.D.

Medical Director, Molecular Genetic Pathology and Interim Co-Executive Director

Knight Diagnostic Laboratories, Oregon Health & Science University Professor of Pathology, OHSU

Biographical Sketch

Dr. Press received his M.D.and Ph.D. from Case Western Reserve University in Cleveland, Ohio.  He completed his pathology and molecular pathology residencies at the University of Pennslyvania.   Dr. Press is board-certified in Clinical Pathology and Molecular Genetic Pathology. 

Dr. Press is the program director for the Molecular Genetic Pathology Fellowship. His research interests include molecular diagnostic biomarkers in cancer, infectious diseases and prevalent genetic alterations in common diseases. He has authored or co-authored more than 90 publications.

pressr@ohsu.edu

Elsevier pure profile

SELECTED PUBLICATIONS

1. Curtis A. Lachowiez, Nicola Long, Jennifer Saultz, Arpita Gandhi, Laura F. Newell, Brandon Hayes-Lattin, Richard T. Maziarz, Jessica Leonard, Daniel Bottomly, Shannon McWeeney, Jennifer Dunlap, Richard Press, Gabrielle Meyers, Ronan Swords, Rachel J. Cook, Jeffrey W. Tyner, Brian J. Druker, Elie Traer. Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia Blood advances May 9, 2023 Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
2. Maedeh Mohebnasab, Peng Li, Bo Hong, Jennifer Dunlap, Elie Traer, Guang Fan, Richard D. Press, Stephen R. Moore, Wei Xie. Cytogenetically Cryptic Acute Promyelocytic Leukemia. International Journal of Molecular Sciences Sep 2023 Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge
3. Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H. Tong, Felicitas L. Lacbawan, Frederick K. Racke, Richard D. Press. NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia. Blood Cancer Journal Dec 2023 NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia
4. Wei Xie, Philipp W. Raess, Jennifer Dunlap, Cristina Magallanes Hoyos, Hongmei Li, Peng Li, Ronan Swords, Susan B. Olson, Fei Yang, Tauangtham Anekpuritanang, Shimin Hu, Joanna Wiszniewska, Guang Fan, Richard D. Press, Stephen R. Moore. Adult acute myeloid leukemia patients with NUP98 rearrangement have frequent cryptic translocations and unfavorable outcome. Leukemia and Lymphoma 2022 Adult acute myeloid leukemia patients with NUP98 rearrangement have frequent cryptic translocations and unfavorable outcome
5. Mara W. Rosenberg, Samantha L. Savage, Christopher A. Eide, Anna Reister Schultz, Rachel Cook, Richard Press, Carole Rempfer, Garrett Eickelberg, Beth Wilmot, Shannon K. McWeeney, Jeffrey W. Tyner, Brian J. Druker, Cristina E. Tognon. Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia. Cold Spring Harbor molecular case studies Oct 1, 2022 Comprehensive molecular characterization of a rare case of Philadelphia chromosome–positive acute myeloid leukemia
6. Wei Xie, Guang Fan, Joanna Wiszniewska, Richard D. Press, Fei Yang. Histopathological and molecular findings in a patient with Ras-associated autoimmune leukoproliferative disorder. Human Pathology Reports Sep 2022 Histopathological and molecular findings in a patient with Ras-associated autoimmune leukoproliferative disorder
7. Fei Yang, Nicola Long, Tauangtham Anekpuritanang, Daniel Bottomly, Jonathan C. Savage, Tiffany Lee, Jose Solis-Ruiz, Uma Borate, Beth Wilmot, Cristina Tognon, Allison M. Bock, Daniel A. Pollyea, Saikripa Radhakrishnan, Srinidhi Radhakrishnan, Prapti Patel, Robert H. Collins, Srinivas Tantravahi, Michael W. Deininger, Guang Fan, Brian Druker, Ujwal Shinde, Jeffrey W. Tyner, Richard Press, Shannon McWeeney, Anupriya Agarwal. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML. Blood Feb 24, 2022 Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML
8. William Shomali, Alisa Damnernsawad, Talent Theparee, David Sampson, Quinlan Morrow, Fei Yang, Sebastian Fernandez-Pol, Richard Press, James Zehnder, Jeffrey W. Tyner, Jason Gotlib. A novel activating JAK1 mutation in chronic eosinophilic leukemia. Blood advances Sep 28, 2021 A novel activating JAK1 mutation in chronic eosinophilic leukemia
9. Aaron M. Tsumura, Brian J. Druker, Diana Brewer, Richard Press, Theodore P. Braun. BCR-ABL+ chronic myeloid leukemia arising in a family with inherited ANKRD26-related thrombocytopenia. JCO Precision Oncology 2021 BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia